Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$10M | 1 yr ago

About Oxford Endovascular

Oxford Endovascular is developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (flow diverter) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.

Oxford Endovascular Headquarters Location

G4 Magdalen Centre, Robert Robinson Avenue Oxford Science Park

Oxford, England, OX4 4GA,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Oxford Endovascular

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Oxford Endovascular is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Oxford Endovascular Patents

Oxford Endovascular has filed 1 patent.

The 3 most popular patent topics include:

  • Angiology
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date


Related Topics




Vascular diseases, Dosage forms, Angiology, Drug delivery devices, Neurosurgery


Application Date


Grant Date



Related Topics

Vascular diseases, Dosage forms, Angiology, Drug delivery devices, Neurosurgery



Latest Oxford Endovascular News

Worldwide Neurovascular Devices Industry to 2026 - Emerging Research Activities in the Field of Neurovascular Therapies Presents Opportunities

Oct 15, 2021

Market Statistics The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period. Market Segmentation & Coverage This research report categorizes the Neurovascular Devices to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Disease Pathology, the market was studied across Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, and Stenosis. Based on Devices, the market was studied across Cerebral Angioplasty and Stenting Systems, Cerebral Embolization and Aneurysm Coiling devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty and Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization and Aneurysm Coiling devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires. Based on End-user, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Competitive Strategic Window The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurovascular Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurovascular Devices Market, including Abbott Laboratories, Acandis GmbH, B. BRAUN MELSUNGEN AG, Cerus Endovascular Inc., Evasc Medical Systems, Gynesonics, Inc., Integer Holdings Corporation, Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Microport Scientific Corporation, Oxford Endovascular Ltd, Penumbra, Inc., phenox GmbH, Rapid Medical, Secant Group, LLC, Sensome, Stryker Corporation, and Terumo Corporation. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Neurovascular Devices Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Devices Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Devices Market? 4. What is the competitive strategic window for opportunities in the Global Neurovascular Devices Market? 5. What are the technology trends and regulatory frameworks in the Global Neurovascular Devices Market? 6. What is the market share of the leading vendors in the Global Neurovascular Devices Market? 7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Devices Market? Key Topics Covered:

Oxford Endovascular Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Oxford Endovascular Rank

  • When was Oxford Endovascular founded?

    Oxford Endovascular was founded in 2015.

  • Where is Oxford Endovascular's headquarters?

    Oxford Endovascular's headquarters is located at G4 Magdalen Centre, Robert Robinson Avenue, Oxford.

  • What is Oxford Endovascular's latest funding round?

    Oxford Endovascular's latest funding round is Series A.

  • How much did Oxford Endovascular raise?

    Oxford Endovascular raised a total of $12.96M.

  • Who are the investors of Oxford Endovascular?

    Investors of Oxford Endovascular include Vulpes Investment Management, Additio Investment Group, EIT Health, Parkwalk Advisors, Oxford Sciences Innovation and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.